Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Офтальмология / Английские материалы / Clinical Medicine in Optometric Practice_Muchnick_2007

.pdf
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
13.69 Mб
Скачать

392 INDEX

Pregnant patients (Continued) retinal diseases in, 352-354 sudoriferous cysts in, 217-218 toxoplasmosis and, 189

Premalignant epithelial lesions, 219 Prerenal acute renal failure, 96 Preretinal hemorrhages, 276 Presbycusis, 14

Preseptal cellulitis, 180 Presumed ocular histoplasmosis

syndrome (POHS), 188 Primary biliary cirrhosis, 112 Primary chronic headaches, 269-274

Progressive supranuclear palsy (PSP), 236, 260, 280

Prolactin-secreting pituitary tumors, 239 Proliferative diabetic retinopathy (PDR),

130-131, 131f Proliferative retinopathies, 195

nonproliferative diabetic retinopathy (NPDR), 127-133, 130, 130f, 131

proliferative diabetic retinopathy (PDR), 131-133

Proliferative sickle-cell anemia (SCA), 195

Pronator drift, 31 Proptosis, 68, 138 Prostaglandins, 152 Prostate, 25

Protein abnormalities, 196, 196t, 341 Proteinuria, 47, 97

Protozoal infections, 189f, 206 Pruritus, 107, 108, 112, 195, 213, 294

Pseudomonas, 182

Pseudotumor cerebri (PTC), 15, 192, 237, 354

Psoriasis, 16, 205, 215

PSP (progressive supranuclear palsy), 236, 260, 280

Psychiatric history. See mental health PTCA (percutaneous transluminal

coronary angioplasty), 85 PTC (pseudotumor cerebri), 237 Pterygium, 17

Ptosis, 11, 33, 153f, 234, 276, 301, 352 PTRF (parapontine reticular formation),

255-256 Puberty, 128

PUD (peptic ulcer disease), 114 Pulmonary disease. See lungs/pulmonary

diseases Pulse rate, 14, 15f

Punctal occlusion, 96, 97, 346 Punctate staining, 115f Pupils

abnormal, 246-247

Adie’s pupil, 14, 32, 251, 252-253, 253f afferent pupillary pathway lesions, 248 anatomy of, 244f

anisocoria, 11-12, 243, 245, 247 with anterior uveitis, 303

Pupils (Continued)

Argyll Robertson pupil, 32, 187, 250b constriction of, 33

diagnostic pharmacology, 252, 252t distortion of, 307

fixed, dilated, 251

inadvertent mydriatic instillation, 253 iris etiologies of dysfunction of, 247b light-near dissociation (LND) pupil,

250

light reflexes, 243, 245f, 246f Marcus Gunn pupil, 163 measurement of, 245

neuroophthalmic disturbances of, 248 observation of, 243

pupillary cycle times, 246 recording responses, 246 relative afferent pupillary defect

(RAPD), 163, 247-248, 250 response of, 245f

swinging flashlight test, 243-246 tonic, 251-252

vermiform movements of, 251-252 Pupil sparing oculomotor palsies,

262-263 Purple-colored lesions, 207 Purpura, 206

Pursuit system, 254-255, 254f Pustular dermatoses, 207 Pustules, 16, 204 Pyelograms, 14

Pyoderma gangrenosum, 119f Pyridoxine acid (vitamin B6), 117 Pyuria, 14

R

Radiation therapy, 142-143, 198 Radioactive iodine-uptake (RAIU) test,

134 Radiology

angiography, 67f

computed tomography (CT) scan, 62 cranial imaging, 224-227

diagnostic imaging techniques computed tomography (CT scan),

55-57

isotope scans, 58-59

magnetic resonance imaging (MRI), 57-58

orienting the image, 61-64 plain films, 54-55

positron emission tomography (PET), 58

ultrasonography, 59-61 diagnostic implications of, 69-70 Doppler imaging, 61f

of eye and orbit

computed tomography (CT scan), 66-68

MRI (functional magnetic resonance imaging), 68

Radiology (Continued) plain films, 64-66 ultrasonography, 69

GI series, 114

history/overview of x-rays, 53-54 optic scans, 66f, 67f

orienting the image (planes of body), 61-62, 61f, 62f

for respiratory diseases, 102 roentgenograms, 225f

skull films, 62

x-rays, 53-54, 54f, 55f, 63f, 183f Raised skin lesions, 203

RAIU (radioactive iodine-uptake) test, 134

Rales, 21

RAPD (relative afferent pupillary defect), 163, 244-248, 245, 246f, 250, 330

Rapid plasma reagin (RPR), 187 Rapid plasma reagin (RPR) test, 51

RA (rheumatoid arthritis). See rheumatoid arthritis (RA)

Rashes. See skin/dermatology Lyme disease, 184f syphilis, 315f

systemic lupus erythematosus (SLE), 158f

Rathke’s pouch, 239-240 Raymond’s syndrome, 241 Raynaud’s phenomenon, 160, 325 RBC (red blood cell count), 41-43,

192, 193

RDW (red blood cell distribution width), 42

Reaction types (allergic), 151 Reactive arthritis (ReA) (Reiter’s

syndrome), 49, 161-162, 312-313t, 316, 341

Reason for visit. See chief complaint/ reason for visit

Recovery position, 291 Rectal examinations, 23, 114 Recurrent uveitis, 300

Red blood cell count (RBC), 41-43, 192, 193

Red blood cell distribution width (RDW), 42

Red cell distribution, 192 Red eye, 302, 303 Reductase, 47 Referrals/consults

ADD/ADHD, 286-287

Argyll Robertson syndrome, 250 carotid workups, 21

complications of osteoarthritis, 164-165 Crohn’s disease, 314

erythroderma with systemic signs/ symptoms, 205

Graves’ disease, 134 hernias, 23

hives with fever, 206-207

 

 

INDEX

393

Referrals/consults (Continued)

Retina (Continued)

Rheumatoid arthritis (RA), 24, 48-49,

 

in-office injuries, 290-291

emboli in retinal artery tree, 91f

158-159, 159f

 

neurologic, 11, 29, 229, 265

examination of, 308

Rheumatoid factor, 316, 324, 325

 

oral masses or bleeding, 18

hemorrhages, 80, 172f, 192, 327, 354

Rhinitis, allergic, 17, 152

 

pregnant patients with diplopia/

HSV-related retinopathy, 177

Rhodopsin, 347

 

retinal hemorrhages, 354

hypertensive retinopathy, 80f, 98-99,

Rhonci, 21

 

retinal evaluations, 307

319-322

Riboflavin (vitamin B2), 116

 

space-occupying lesions, 266

intraretinal hemorrhages, 325

Rickets, 115-116

 

transient blur-outs/dimming of

intraretinal microvascular abnormali-

RINDs (reversible ischemic neurologic

vision, 86

ties (IRMAs), 128, 129-130

deficits), 231

 

transient ischemic attacks (TIAs), 231

Kimmelstiel-Wilson retinopathy, 127

Rinne test, 18f

 

vascular examinations, 86, 322

lesions of, 249t

Risk factors

 

Vogt-Koyanagi-Harada syndrome

leukemic retinopathy, 197-198

acute myocardial infarctions

 

(VKH), 208

lupus-related retinopathy, 324

(MIs), 83

 

Reflexes

metastasis of breast cancer to, 22

atherosclerosis, 75, 77, 83, 87

 

accommodation, 251

necrotizing retinitis, 330

cancer, 199

 

blink, 136

nonproliferative diabetic retinopathy

cataract development, 344-345

 

corneal reflex test, 34, 35

(NPDR), 128-133, 130, 130f, 131

chronic obstructive pulmonary

 

evaluation of, 31-32, 33f

nonproliferative retinal hemorrhages,

disease (COPD), 102

 

gag, 37

195

colon cancer, 23

 

near pupillary, 246, 251

nonrhegmatogenous retinal

delirium, 283

 

pupillary, 245f

detachment, 99

diabetes mellitus, 125, 128, 133

 

Reiter’s syndrome (reactive arthritis

ocular complications of chemother-

endocrine ophthalmopathy

 

(ReA), 49, 161-162, 312-313t,

apy in, 201

(EO), 141

 

316, 341

peripheral retinal vessels, 308

in general, 73-74

 

Relative afferent pupillary defect

pregnancy-related diseases of, 352-354

heart attacks, 293

 

(RAPD), 163, 244-246, 245, 330

presentation of, in histoplasmosis, 188

hepatic diseases, 109-110

 

Renal retinopathy, 98-99. See also

proliferative diabetic retinopathy, 131f

for HIV, 169

 

kidneys/kidney disease; retina

renal retinopathy, 98-99

hypertension, 78

 

Respiratory system. See under lungs/

retinal arterial emboli, 322-323

ischemic heart disease, 82

 

pulmonary diseases

retinal arteriosclerosis, 79f

malignant melanoma, 211

 

RESTASIS (cyclosporin A), 346

retinal detachments (RDs), 68, 98,

office sanitation for, 9-11

 

Retina

99, 272

progression to proliferative diabetic

acquired syphilitic retinopathy, 327

retinal pigment epithelium (RPE),

retinopathy, 130-131

 

acute retinal necrosis (ARN), 330

68, 330, 347

schizophrenia, 285

 

anomalous retinal correspondence,

retinal tears (rhegmatogenous

strokes, 229-230

 

258

RDs), 68

systemic disease and uveitis, 300

 

arterial plaques, 73, 76

retinitis, 300

thrombogenesis, 84

 

arteriosclerosis, 14, 79

retinitis pigmentosa (RP), 342

RNA, 340

 

atherosclerosis effects on, 76

retinoblastoma, 68

Roentgen,William Konrad, 53

 

boxcarring of retinal vessels, 188

sea fan neovascularization (in sickle-

Romberg test, 32f

 

branch retinal artery occlusions, 73-74

cell anemia), 195

Rosenbach’s sign, 14, 137

 

candle-wax drippings, 164, 308, 327f

Seigert’s streaks, 99

Ross River disease, 347

 

central retinal artery occlusion

sickle cell anemia related retinopathy,

RPR (rapid plasma reagin), 187

 

(CRAO), 163, 323

97

RPR (rapid plasma reagin) test, 51

 

central retinal vein occlusion

slit lamp evaluation of, 308

Rubella (German measles), 179, 330

 

(CRVO), 120

systemic hypertension effects on,

Rubeola (measles), 178-179, 330

 

central serous chorioretinopathy

79, 320

Rubeosis iridis, 86, 86f, 132, 132f,

 

(CSC), 353

toxic retinopathy, 334-335

323

 

chorioretinitis, 180, 328f

toxoplasmosis, 189f

S

 

CMV retinitis, 330

toxoplasmosis retinochoroiditis, 189

 

 

 

cotton-wool spots, 331f

Retinitis, 332f

Saccadic system, 253, 255-256, 255f

 

cytomegalovirus infections retinopathy,

Retinol (vitamin A), 115

Sacroiliitis, 49

 

172

Retrobulbar optic nerve, 240

Salivary glands, 49, 159

 

cytomegalovirus retinitis, 172f

Revascularization procedures, 87

SA node dysfunction, 90

 

diabetic retinopathy, 127-131, 127-133,

Reverse relative afferent pupillary defect

SAPPHIRE study, 232

 

128, 131

(RAPD), 250, 251b

Sarcoidosis, 49, 145, 163-164, 206, 303f,

diseases of, affecting pupillary

Reversible ischemic neurologic deficits

308, 308f, 312-313t, 315f, 316,

 

response, 248

(RINDs), 231

326f, 327

 

edema, 129

Reye’s syndrome, 111

Sawtooth nystagmus, 257

 

Elschnig spots, 99

Rheumatic heart disease, 87, 89

Scales, 204, 215

 

394

INDEX

 

 

SCA (proliferative sickle-cell anemia),

Sixth cranial (abducens) nerve, 35, 241,

Skin/dermatology (Continued)

 

195

261, 265-267

pimples, 16

Scars, 204

Sjögren’s syndrome, 48, 49, 97, 113,

premalignant epithelial lesions, 219

SCA (sickle-cell anemia), 98, 194-195

159-160, 325, 342, 346

processes and systemic consider-

SCC (scleroderma), 159-160, 160-161,

SJS (Stevens-Johnson syndrome), 156,

ations of, 203

 

324-325

207, 208, 216

psoriasis, 215

Schedule II drugs, 287

Skew deviation, 258

pustular dermatoses, 207

Schizophrenia, 285

Skin/dermatology

raised lesions, 203

Scintillating scotomas, 272

actinic keratosis, 220b, 220f

Reiter’s syndrome lesions, 311

Sclera, 108, 119, 119f, 159, 325

Addison’s disease changes, 146

sarcoidosis problems of, 164, 315f

Scleritis, 159f

alopecia, 205-206

seborrheic dermatitis, 215

Scleroderma (SCC), 159-160, 160-161,

angioedema, 207

skin-colored lesions, 207

 

160f, 324-325

atopic dermatitis, 153, 154, 154f,

skin tags on eyelids, 217

Scleromalacia perforans, 159, 159f

213-214

smallpox lesions, 178

Sclerosing basal cell carcinoma, 220, 221

basal cell lesions, 17, 219-221, 220f,

Sturge-Weber syndrome, 208

Sclerosis, arteriolar, 321, 348

220t, 251

syphilitic lesions, 186, 313

Sclerotic phase of hypertensive retinop-

benign elevated ocular tumors,

systemic lupus erythematosus (SLE)

 

athy, 320-321

217-219

rash, 158

Scoliosis, 14

benign versus malignant skin

trauma, 204

Scopolamine transdermal patches, 253

characteristics, 16t

tuberculosis lesions, 182, 182f

Scotomas, 76, 272

bullous dermatosis, 155

types of lesions, 204, 204t

Scurfs, 215

butterfly rashes, 324

urticaria, 206-207

Sebaceous cysts, 218

cicatricial pemphigoid, 155, 155f

vesicular dermatoses, 207

Seborrheic dermatitis, 215

color indicators, 16, 204

warts (See verrucae)

Seborrheic keratosis, 218, 219f

contact dermatitis, 207, 214, 214f

Skull films, 61, 62

Secondary hypertension, 78

crusts, 204

SLE (systemic lupus erythematosus), 49,

Secondary subacute headaches, 274-275

dandruff, 215

97, 157-158, 206, 324

Second cranial (optic) nerve, 33, 240

dermatological reactions to drugs/

Slit-lamp biomicroscopy

Sedimentation rate, 46, 158, 163

medications, 208

anterior chamber angle, 307

Seigert’s streaks, 98, 99

dermatomyositis, 235

conjunctiva, 305

Seizures, 228, 229, 292b

diabetes mellitus and, 24

cornea, 305-306

Sella, 145

diseases of pregnant patients, 352

iris, 306-307

Senile sebaceous hyperplasia, 218

documentation of lesions, 16

lens, 307

Sensitization, 151

eczema, 214-215

optic nerve head, 308

Sensorineural hearing loss, 242

elevated lesions, 213-214

retina, 308

Sensory distribution of trigeminal

erythema migrans, 184, 205

vitreous, 308

 

nerve, 35

erythema multiforme, 208

Small intestine, 114

Sensory division test, 34

erythema nodosum, 118

Smallpox (variola), 178

Sensory functions, 30

erythematous plaques, 203

Smell, loss of, 33, 34f

SEPs (somatosensory evoked potentials),

erythroderma, 204-205

Smoking cessation, 102, 347

 

224

examinations, 7, 12, 16-17

Smooth pursuit system, 253

Septicemia, 181

figurate lesions, 205

Smooth tongue, 117, 117f

Sequential (or simultaneous) multiple

flat lesions, 207-208

Snowballs, 308

 

analysis (SMA-12), 43

herpes simplex virus (HSV) dermatitis,

Social behavior, 285

Serum alanine levels, 108

176, 204b

Social history, 7

Serum albumin levels, 46

herpes zoster virus lesions, 173

Soft exudates, 80

Serum lipids, 131

hives, 152

Somatic efferent fibers, 33

Serum sickness, 207

hypopigmentation, 205

Somatosensory evoked potentials

Seventh cranial (facial) nerve, 34, 35-36,

in inflammatory bowel disease

(SEPs), 224

 

208, 241-242

(IBD), 118

Sonography, 59-61

Sexually transmitted diseases (STDs).

Lyme disease rash, 184, 315, 316

Space-occupying lesions, 280

 

See STDs (sexually transmitted

malignant cutaneous lesions,

Specific gravity of urine, 47

 

diseases)

219-221

Speech problems, 29

Shimmering phenomenon, 272

melanoma, 16, 209, 210-213, 212b,

Spermatoceles, 23

Sickle-cell anemia (SCA), 98, 194-195

212f, 213b, 213f

Sphygmomanometers, 14

Sigmoidoscopes, 23

nevi, 208-210, 209b, 209f, 209t,

Sphygmomanometry, 87

Signs/symptoms. See diagnostic signs

210f, 211f

Spider angiomas, 16, 107, 108f, 352

 

and symptoms/diagnostic testing

ocular atopic dermatitis, 214

Spinal accessory nerve, 243

Simultanagnosia, 281

papillomas, 217t

Spinal cord, 30, 227, 232

Sinus headaches, 270t

papulonodular lesions, 207

Spinal examinations, 24

Sinusitis, 273

pemphigus vulgaris, 153, 155

Spinal problems, 161

SPK (superficial punctuate keratitis), 116, 176, 181

Spleen, 23 Spondyloarthropathies, 49 Sputum, 14

SQ (subcutaneous) route for injections, 367-371

Squamous cell carcinoma, 18, 221-222 Squamous metaplasia, 346

Squamous papillomas, 217 SRNVM (subretinal neovascular

membrane), 188 Standards of care, 295 Staphylococcus infections, 180 Status epilepticus, 229

STDs (sexually transmitted diseases) chlamydial infections, 187-188 genital warts, 216

gonorrhea, 181-182, 181f human papilloma virus, 178 syphilis

alopecia in, 206

Argyll Robertson syndrome, 250 laboratory testing for, 51 neurosyphilis, 187, 282

ocular findings in, 312-313t in pituitary gland, 145

posterior manifestations of, 327 rashes in, 315

retinal manifestations of, 308 stages of, 185-187

Stellwag’s sign, 14, 136 Stem cells, 191 Stenosis, 83

aortic, 91 flow-limiting, 75 mitral, 90-91 tricuspid, 92

Steroids, 146, 233, 302, 309, 310, 355 Stethoscopes, 14, 21

Stevens-Johnson syndrome (SJS), 156, 156f, 207, 208, 216

Stomach evaluation, 114 Stomatitis, 14, 117f

Strabismus, 258. See also extraocular muscles (EOMs); ocular motility dysfunction

Streptococcus infections, 180 Stressors, 347, 348

Stress tests, 82

Strokes (cerebrovascular accidents), 79, 229-232, 292b, 323

Strokes/cerebrovascular disease, 79, 229-232, 292, 323

Structural brain lesions, 224 STS group of tests, 51 Sturge-Weber syndrome, 208

Subarachnoid abducens nerve palsies, 266

Subarachnoid fourth-nerve palsy, 265 Subarachnoid hemorrhages, 251, 270t

Subclavian steal syndrome, 228 Subcutaneous insulin infusion (CSII), 127 Subcutaneous (SQ) route for injections,

367-371

Subhyaloid preretinal hemorrhages, 276 Submucosal hematomas, 194

Subretinal neovascular membrane (SRNVM), 188

Sudoriferous cysts, 217-218 Suicide, 283, 284, 285 Suker’s sign, 137

Sun exposure, 210

Superficial basal cell carcinoma, 220 Superficial punctuate keratitis (SPK),

115f, 116, 176, 181

Superficial spreading melanoma, 212 Superior orbital fissure fourth-nerve

palsy, 265 Suppression of vision, 254 Supranuclear palsy, 256 Surgical treatment

for advanced osteoarthritis, 165 angina pectoris, 83

aortic valve reconstruction (AVR), 91, 92

brain tumors, 239-240

breaking of anterior synechiae, 307 cancer, 198

carotid endarterectomy, 86, 232, 322-323

cataracts, 344

for chronic obstructive pulmonary disease (COPD), 103

embolectomy, 105

endocrine ophthalmopathy (EO), 144 hypertensive retinopathy, 321-322 hyperthyroidism, 135

increased intracranial pressure, 238 mitral regurgitation, 91

mitral valvotomy, 91 Mooren’s ulcer, 155 myasthenia gravis (MG), 234

ocular ischemic syndrome, 323 orbital decompression, 143 parkinsonianism, 236

for pheochromocytoma, 147 revascularization procedures, 87 ruptured aneurysms, 276 squamous cell carcinoma, 222

Swallowing difficulties, 113, 325 Swinging flashlight test, 243-246, 245 Sylvian aqueduct, 249t

Symblepharon, 115f, 116, 155, 156, 178 Sympathetic efferent system lesions,

249t

Sympathetic pupillary light reflex pathway, 244f

Symptoms. See by disease, disorder, or process; chief complaint/reason for visit; diagnostic signs and symptoms/ diagnostic testing

INDEX 395

Syncope, 228, 290-291, 290b Synechiae, 247, 307f Synovial fluid analysis, 48 Synovitis, 158

Syphilis, 315f, 328f alopecia in, 206

Argyll Robertson syndrome, 250 laboratory testing for, 51 neurosyphilis, 187, 282

ocular findings in, 312-313t in pituitary gland, 145

posterior manifestations of, 327 rashes in, 315

retinal manifestations of, 308 stages of, 185-187

Syringomas, 218

Systemic effects of allergic responses, 151

Systemic hypertension, 131, 229 control of, 76

drug treatment for, 81-82 effects of, 79-81 essential, 78

genetics of, 341 malignant, 81

ocular ischemic syndrome in, 323 posterior segment manifestations of,

319-322 pregnancy-induced, 78, 352-353 prognostic indicators in, 78 retinal arteriosclerosis in, 79f secondary, 78

third cranial nerve involvement in, 241

Systemic lupus erythematosus (SLE), 49, 97, 157-158, 158f, 206, 324

T

T3 suppression test, 134 Tabes dorsalis, 282 Taboparesis, 282 Tachyarrhythmias, 89-90 Tachycardia, 14

Tactile sense, evaluation of, 30f Talc retinopathy, 334 Tamoxifen retinopathy, 334-335 T cell lymphoma, 204-205

Tcells, 43, 136, 142, 151-152, 153, 156,

163.See also HIV/AIDS

Tears. See lacrimal system Technetium scans, 58-59, 58f Teeth, 187, 271t Telangiectasias, 16, 203, 204 Temperature, patient’s, 15f

Temporal arteritis (giant-cell arteritis [GCA]), 162-163, 163f, 270t, 274, 323-324

Temporomandibular joint syndrome (TMJ), 273-274

Tension headaches, 270t Tension-type headaches, 273

396 INDEX

Tenth cranial (vagus) nerve, 37, 242 Terminally ill patients, 283 Testicular cancer, 23

Testing. See diagnostic signs and symptoms/diagnostic testing; laboratory testing

Tetanus, 181 Thalassemia, 42, 195 T-helper cells, 168 Thiamine (vitamin B), 116

Third cranial (oculomotor) nerve, 33, 34, 260-261

clinicopathologic correlates of, 240-241

efferent third-nerve deficits, 251 lesions of, 249t

orbital third cranial nerve palsy, 241 orbital third-nerve lesions, 251 palsies, 240, 261-263, 267, 276

Throat, 6 Thrombocytopenia, 192, 206 Thrombocytes, 43 Thrombocytopenia, 332-334 Thrombolytic therapy, 232

Thrombotic thrombocytopenia purpura (TTP), 193, 197, 333-334, 354

Thrombus formation, 20-21, 73, 74-75 Thyroid disorders, 49-50. See also

endocrine system/disorders alopecia in, 206

examination of thyroid, 19-20 Graves’ disease (endocrine

ophthalmopathy [EO]), 11, 50, 67, 68, 69

diagnosis of, 136-141 hormones, role of, 123-124 names synonymous with, 133 overview of, 135

overview of/terminology related to, 133-134

pathogenesis of, 136 symptoms of, 136-141 Hashimoto’s thyroiditis, 136 hyperthyroidism, 14, 134-135 hypothyroidism, 135-136, 145

palpation of thyroid, 19f thyroid ophthalmopathy, 68

Thyroid function tests, 134-136 Thyroid-releasing hormone (TRH), 50 Thyroid-stimulating hormone (TSH), 50 TIAs (transient ischemic attacks). See

under ischemia Tick-borne diseases, 183-185 Ticlopidine, 231

Tics, 236 Tinnitus, 242

T lymphocytes, 144, 150

TMJ (temporomandibular joint syndrome), 273-274

Tomograms, 57f Tongue, 117, 117f, 310f

Tonic-clonic seizures, 229 Tonic pupils, 32, 251-252 Tophi nodules, 165 Torticollis, 33

Tortuosity of retinal veins, 321 Torus palatinus, 17

Total cholesterol levels, 45 Total serum protein levels, 46

Toxic environment, 267, 344, 345 Toxicity, 115-117, 334-335 Toxocariasis, 189-190, 332, 333f Toxoplasmosis, 189, 199, 332, 332f,

333, 333f Trabeculitis, 177 Trachoma, 187-188

Transaminases (aminotransferases), 44 Transcription, 340

Transient ischemic attacks (TIAs). See under ischemia

Translation, 340 Transplantation of organs, 97 Trauma

anterior uveitis and, 300 head/cranial nerves, 262, 265 iris, 247

oculomotor nerve, 267 orbital floor, 18

sixth cranial nerve, 266 skin, 204

Treatment protocols. See specific disease or disorder

Tremors, 235 Treponemal tests, 51, 314

TRH (thyroid-releasing hormone), 50 Trichiasis, 156

Tricuspid regurgitation (TR), 92 Tricuspid stenosis (TS), 92 Trigeminal (fifth cranial) nerve, 33-35,

35f, 174f, 175f, 241, 271t, 275 Trochlear (fourth cranial) nerve, 33, 34,

241, 261, 263-265

Tropheryma whippelii, 114-115 TSH-IRMA test, 134

TSH (thyroid-stimulating hormone), 50, 145

TS (tricuspid stenosis), 92

TTP (thrombotic thrombocytopenia purpura), 193, 197, 333-334, 354 Tuberculosis, 145, 157, 173, 182-183, 182f, 183, 312-313t, 314, 326-327

Tumor markers, 199 Tumors

adrenal, 78

anterior chamber, 307 benign ocular, 200-201 brain, 238-240, 274-275, 280

of central nervous system, 238t conjunctival, 200f

definition of, 203, 204 dementia caused by, 282 endocrine system, 124

Tumors (Continued) intraocular, 199-201, 304 iris, 246-247 meningioma, 239 pituitary, 145-146

sixth cranial nerve, 266 uveal tract, 68

Tuning forks, 18-19, 18f, 30

Twelfth cranial (hypoglossal) nerve, 38, 38f, 243

Type 1 and 2 diabetes mellitus, 127, 341. See also diabetes mellitus (DM)

Type I hypersensitivity reactions, 151-153, 301

Type II (cytotoxic) reactions, 151 Type II diabetes, 77

Type II hypersensitivity reactions, 153-156

Type III hypersensitivity reactions, 156-157

Type IV hypersensitivity reactions, 156-157

U

Ulcerations, 118f, 119-120, 120f, 154, 154f, 155, 174, 182, 204, 310, 310f, 347

Ulcerative colitis (UC), 119 Ultrasonography, 22, 23, 59-61, 69, 87

B-mode, 60f, 227

for endocrine ophthalmopathy (EO), 136-141

for liver disease, 108

Unilateral pursuit system disorders, 255 Upgaze palsies, 260

Upper visual pathway lesions, 250 Urethritis, 161

Uric acid, 44-45

Urinalysis, 46-47, 47-48, 51. See also kidneys/kidney disease

Urobilinogen, 47

Urogenital system. See genitourinary system

Urticaria, 206-207, 206b Urticaria (hives), 152, 206-207 U.S. Public Health Service, 51 Uvea, 201

Uveitis, 18, 23. See also anterior chamber anterior, 119, 145, 164, 183, 247 characteristics of, 310

chronic, 164

classification of, 300, 310-311 collagen-vascular diseases and,

311-312 diagnosis, 303-308

history of condition, 302-303 infectious diseases and, 314-316 inflammatory diseases and, 312-314 injection in, 305f

laboratory findings in, 316 Lyme disease related, 184

mitigation of inflammation, 308-309

INDEX 397

Uveitis (Continued) overview of, 299-300

pathophysiology of, 300-301 posterior synechiae prevention,

309-310 recurrent, 310

resistance to treatment, 310 with sarcoidosis, 164

slit-lamp biomicroscopy with, 306-308 symptomatic relief, 309

symptoms of, 301-302

when to suspect systemic diseases with, 316

V

Vaccinations. See immunizations/ vaccinations

Vagus (tenth cranial) nerve, 34, 37, 242 Valvular diseases (heart)

aortic regurgitation (AR), 91-92 aortic stenosis (AS), 91

mitral regurgitation (MR), 91 mitral stenosis (MS), 90-91 mitral valve prolapse (MVP), 91 tricuspid regurgitation (TR), 92 tricuspid stenosis (TS), 92

Varicella, 11

Varicella-zoster virus (VZV), 173-175 Varicoceles, 23

Variola (smallpox), 178

Vascular disease. See also arterial diseases; circulatory system; hypertension

atherosclerosis, 74-75, 76-77 carotid artery disease, 85-86

coronary artery disease, 82-83, 83-85 hypertension, 79-81, 81-82 (See also

systemic hypertension) myocardial infarction, 83-84 peripheral vascular disease, 87 risk factors for, 73-74, 75, 77, 78 vascular abnormalities in diabetic

retinopathy, 128

vascular autoimmune diseases, 162-163 vascular occlusive palsy, 241 vasculitis, 162

vertebral-basilar insufficiency, 86-87 Vascular injuries, 98

Vascular therapy of increased intracranial pressure, 237

Vasoconstrictive phase of hypertensive retinopathy, 320

Vasodilators, 81 Vasovagal syncope, 228

VDRL (venereal disease research laboratory) test, 51

Venereal disease research laboratory (VDRL), 187, 314

Venipuncture, 41 Venous beading, 130

Venous stasis retinopathy, 323 Ventricular fibrillation (VF), 90

VEPs (visual evoked potentials), 224 Vergence system, 253, 257-258 Vermiform movements of pupil, 251-252 Vernal keratoconjunctivitis, 153 Verrucae

characteristics of, 216t common warts, 217f

verruca plana (flat warts), 216, 216t, 217

verruca vulgaris (HPV), 178, 216, 217 warts, 178, 216, 217

Verruca plana (flat warts), 216, 217 Verruca vulgaris (HPV), 178, 216, 217 Vertebral-basilar insufficiency, 86-87 Vertical gaze palsies, 259-260 Vertigo, 233, 242, 257

Very-low density lipoproteins (VLDLs), 50

Vesicles, 16, 203, 204 Vesicular dermatoses, 207

Vessel narrowing, 79. See also neovascularization

Vestibular disease, 256-257 Vestibular eye movements, 257f Vestibular nystagmus, 255 Vestibular-optokinetic system, 253,

256-257

Vestibulocochlear (eight cranial) nerve, 34, 36-37, 242

Vestibulocochlear (eighth cranial) nerve, 36f

VF (ventricular fibrillation), 90 Vibration sense, 30, 31f

Viral infections. See also bacterial infections; infections/infectious diseases

in cancer, 199 cytomegalovirus, 171-172, 199,

330-332

Epstein-Barr virus (EBV), 179-180, 330 hepatovirus, 110

herpetic diseases

chicken pox, 173, 174-175, 315 herpes simplex keratouveitis, 316 herpes simplex keratouveitis (HSV),

316

herpes simplex virus (HSV), 173, 175-178, 175f, 176, 199, 204, 329

herpes zoster ophthalmicus (HZO), 315-316

herpes zoster virus (HZV), 11, 172173, 173-175, 174, 174f, 175f, 199, 329-330

herpetic neuralgia, 175, 271 highly reactive antiretroviral

therapy (HAART), 171 HIV/AIDS, 51, 149, 156, 168-173 human papilloma virus (HPV),

178, 216, 217t measles (rubeola), 178-179 mumps, 179

Viral infections (Continued) ocular findings in, 312-313t overview of, 167

rubella, 330 rubeola, 330

smallpox (variola), 178 varicella-zoster virus (VZV),

173-175

viral conjunctivitis, 12 viral hepatitis, 109-110 viral rhinitis, 17

Virology of HIV, 168

Visceral efferent motor fibers, 33 Vision loss. See also blindness

with anterior uveitis, 301 blurring in pregnancy, 353 disseminated intravascular coagu-

lation (DIC), 197 with histoplasmosis, 188

Hollenhorst plaques and, 322 ischemic optic neuropathy, 163, 240 with measles, 178

in multiple sclerosis, 233

ocular ischemic syndrome (OIS), 323 with temporal cell arteritis, 324 vitamin A deficiency and, 347

with Wegener’s granulomatosis, 324 Visual acuity, 137, 139, 281, 303, 311 Visual axis misalignment, 254

Visual blur, 302

Visual evoked potentials (VEPs), 224 Visual field testing/findings, 17, 33

after strokes, 230-231 Alzheimer’s disease, 281 bitemporal hemianopsia, 146

loss in endocrine ophthalmopathy (EO), 139

optic nerve compression, 139f for pheochromocytoma, 78 pituitary adenomas, 239 pseudotumor cerebri, 237

in Sturge-Weber syndrome, 208 temporal cell arteritis, 163

Visual memory, 281

Visual pathway disturbances, 27 Vital signs, 14-16, 15f

Vitamins

B5 (pantothenic acid), 117 B9 (folic acid), 117

B12, 193, 346

C deficiency, 118f

decreased cataract formation with, 345

A deficiency, 206, 346 uses/effects of, 115-117, 118

Vitiligo, 205, 207-208 Vitreous, 302, 308, 327f

Vitritis, 189, 300, 302, 308, 332f

VKH (Vogt-Koyanagi-Harada syndrome), 208

VLDLs (very-low density lipoproteins), 50

398 INDEX

Vogt-Koyanagi-Harada syndrome (VKH), 208

Voice disorders, 242 Volume of urine, 47 Vomiting, 113

Von Graefe lid lag, 14, 137

VZV (varicella-zoster virus), 173-175

W

Wallenberg’s syndrome, 86, 257 Warfarin, 232

Warts. See skin/dermatology; verrucae Wasserman test, 51

Waste products, 44-45

Watchglass appearance of conjunctiva, 305

Water’ position (radiology), 65

WBC esterase (leukocyte esterase), 47 WBCs (white blood cells), 42-43, 192,

300, 305, 306, 334 Weber test, 19, 19f, 37f

Wegener’s granulomatosis, 162, 324 Weight loss/gain, 14-15, 114, 127 Wernicke’s encephalopathy, 116 Westergren erythrocyte sedimentation

rate, 158 Western blot test, 51 Wheals, 203, 204 Wheezing, 21

Whipple’s disease, 114-115

White blood cells (WBCs), 42-43, 192, 300, 305, 306, 334

Wilder’s sign, 137 Wilson’s disease, 236, 280

Women. See female patients Work history, 4-5

X

Xanthelasmas, 16 Xanthomas, 16 Xerophthalmia, 347 Xerostomia, 160

X-rays, 53-54. See also radiology